Test paper and method for semi-quantitative detection of leucine aminopeptidase
By fixing L-leucine-4-nitroaniline on the test strip and combining specific components, the problem of spontaneous hydrolysis of the substrate affects the detection results is solved, and the rapid and accurate detection of leucine aminopeptidase is achieved, with excellent stability and low cost.
Patent Information
- Application Number
- CN202310766331.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-26
- Publication Date
- 2024-12-27
AI Technical Summary
In the prior art, the detection results of leucine aminopeptidase are not accurate, mainly because the substrate L-leucyl-p-nitroaniline is prone to spontaneous hydrolysis in aqueous solution, which affects the detection results.
The test strips for semi-quantitative detection of leucine aminopeptidase were used, and the filter paper was soaked in the first reaction solution and the second reaction solution and dried, and L-leucine-4-nitroaniline was used as the color development base. Combining magnesium chloride, potassium ferrocyanide and fatty alcohol polyoxyethylene ether, the chromogenic substrate is fixed to avoid spontaneous hydrolysis and improve detection accuracy.
It realizes rapid and accurate detection of leucine aminopeptidase, has simple operation process, short detection time, low detection cost, and is better than conventional kits in stability and linearity, and is suitable for fully automated detection of batch samples.
Smart Images

Figure CN119193761A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the field of detection technology, and in particular to a test paper and method for semi-quantitatively detecting leucine aminopeptidase. Background Art
[0002] Liver disease is a common and extremely harmful disease. Leucine aminopeptidase (LAP, EC3.4.11.1) is widely distributed in tissues such as the liver, pancreas, and kidneys. When there are lesions in the liver, gallbladder, pancreas, and other tissues of the human body, elevated urine LAP levels may occur. The determination of urine LAP can be used as another indicator for non-diagnostic liver disease detection. Its positive detection rate for liver cancer is higher than that of ADA, and it is more sensitive than GGT in reflecting liver disease. The detection of LAP can also reflect the nature and extent of renal damage at an early stage; it can also be used as an effective indicator for dynamic monitoring of pregnancy complicated with ICP and the health of pregnant women and fetuses.
[0003] At present, LAP is generally tested using various large-scale fully automatic biochemical analyzers. However, large-scale fully automatic biochemical analyzers are expensive and complex to operate. Operators need to have relevant professional knowledge and receive corresponding training. They also require high supporting conditions and need to be equipped with a stabilized power supply, a pure water machine, etc. They also occupy a large area and have high maintenance costs. They require regular maintenance by professionals, which is not conducive to their popularization.
[0004] At present, the detection methods for leucine aminopeptidase mainly include continuous monitoring method, L-leucyl-p-nitrobenzene substrate method, dimethylaminobenzaldehyde colorimetric method and fluorescence method, etc.:
[0005] (1) The L-leucyl-p-nitrophenyl substrate method is a relatively simple strategy for detecting leucine aminopeptidase. The basic principle is that LAP catalyzes the hydrolysis of the substrate L-leucyl-p-nitroaniline to generate leucine and p-nitroaniline. The absorbance of the reaction system increases at 405nm, and the activity of LAP in the sample can be obtained by detecting the rate of increase.
[0006] (2) Continuous monitoring method is the current continuous method of determination. It uses the rate of change of absorbance of the consumption of substrate or the production of a certain substance within a certain period of time, that is, △A / min: multiplying it with the factor gives the enzyme activity.
[0007] LAP does not have high requirements for substrate specificity and can hydrolyze a variety of L-leucine derivatives. The enzyme is quantified based on the LAP-catalyzed hydrolysis of each substrate to produce colored aromatic amine derivatives. Currently, L-leucyl-p-nitroaniline (LeupNA) is the most commonly used substrate, but this substrate is often used in liquid double reagents. L-leucyl-p-nitroaniline is prone to spontaneous hydrolysis in aqueous solution, which in turn affects the color change of the substrate, which will greatly affect the test results and lead to poor accuracy of the test results. Summary of the invention
[0008] The purpose of the embodiments of the present application is to provide a test paper and method for semi-quantitative detection of leucine aminopeptidase, which effectively improves the detection results.
[0009] In order to solve the above technical problems, the present application embodiment provides a test paper for semi-quantitative detection of leucine aminopeptidase, which adopts the following technical solution:
[0010] A test paper for semi-quantitative detection of leucine aminopeptidase, comprising:
[0011] Leucine aminopeptidase test paper, blank filter paper, and polyethylene terephthalate substrate;
[0012] Wherein, the leucine aminopeptidase test paper and the blank filter paper are arranged side by side on the polyethylene terephthalate substrate;
[0013] The leucine aminopeptidase test paper is prepared by soaking filter paper in the first reaction solution and the second reaction solution in sequence, and drying both of them;
[0014] The first reaction solution includes a surfactant, and the second reaction solution includes a color developing substrate;
[0015] The chromogenic substrate includes L-leucine-4-nitroaniline or 4-nitro-L-phenylalanine methyl ester hydrochloride.
[0016] Furthermore, the second reaction solution also includes chloride, anti-interference substances and lyophilization protectants.
[0017] Further, the chloride comprises magnesium chloride; and / or
[0018] The anti-interference substance includes potassium ferrocyanide; and / or
[0019] The lyophilization protective agent includes fatty alcohol polyoxyethylene ether.
[0020] Further, the concentration of the chromogenic substrate is 20 to 200 mol / L; and / or
[0021] The concentration of the chloride is 30 to 100 mol / L; and / or
[0022] The concentration of the anti-interference substance is 10 to 50 mol / L; and / or
[0023] The concentration of the lyophilization protective agent is 10-50 mol / L.
[0024] Furthermore, the first reaction solution also includes a buffer and a preservative.
[0025] Furthermore, the pH value of the buffer solution is 6.50-7.50, and the concentration is 0.01-1.0 mol / L; and / or
[0026] The concentration of the surfactant is 5 to 80 g / L; and / or
[0027] The concentration of the preservative is 5 to 300 mol / L.
[0028] Furthermore, the buffer of the first reaction solution is selected from at least one of N-tris(hydroxymethyl)methylamino-2-hydroxypropanesulfonic acid buffer and N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid buffer.
[0029] In order to solve the above technical problems, the present application also provides a method for semi-quantitative detection of leucine aminopeptidase for non-diagnostic purposes, which adopts the following technical solution:
[0030] A method for semi-quantitative detection of leucine aminopeptidase for non-diagnostic purposes, using the above-mentioned semi-quantitative detection of leucine aminopeptidase test paper, comprises the following steps:
[0031] Soak the detection section of the test paper in the urine sample for 1 to 2 seconds;
[0032] The test results are obtained according to the colorimetric card or the detection analyzer.
[0033] Furthermore, the step of obtaining the test result according to the colorimetric card or the detection analyzer includes:
[0034] Allow to react for 60 seconds, compare the reacted test paper with the colorimetric card, and read the test result.
[0035] Furthermore, the step of obtaining the test result according to the colorimetric card or the detection analyzer includes:
[0036] The test paper soaked with the test sample is placed on the urine analyzer and reacted for 60 seconds to obtain the test result output by the urine analyzer.
[0037] Compared with the prior art, the embodiments of the present application have the following beneficial effects:
[0038] The present application uses filter paper as a carrier to generate a test paper, on which a reaction for measuring leucine aminopeptidase can be carried out to achieve rapid measurement. The present application provides a test paper for detecting leucine aminopeptidase with excellent performance and good stability. Compared with conventional test kits, the test paper optimizes its reaction system, and its stability and linear range are better than conventional test kits, which is conducive to promotion and application, and can be used for fully automated detection of batch samples. It has simple operation procedures, short detection time, and low detection cost. BRIEF DESCRIPTION OF THE DRAWINGS
[0039] In order to more clearly illustrate the scheme in the present application, a brief introduction is given below to the drawings required for use in the description of the embodiments of the present application. Obviously, the drawings described below are some embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.
[0040] Figure 1 It is a schematic structural diagram of an embodiment of a test paper for semi-quantitative detection of leucine aminopeptidase according to the present application;
[0041] Figure 2 It is a schematic flow chart of an embodiment of a method for preparing a semi-quantitative test paper for semi-quantitative detection of leucine aminopeptidase according to the present application;
[0042] Figure 3 It is a schematic diagram of a process of an embodiment of a method for semi-quantitative detection of leucine aminopeptidase according to the present application.
[0043] Reference numerals: 101, leucine aminopeptidase test paper; 102, blank filter paper. DETAILED DESCRIPTION
[0044] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by technicians in the technical field of the present application; the terms used in the specification of the application herein are only for the purpose of describing specific embodiments and are not intended to limit the present application; the terms "including" and "having" and any variations thereof in the specification and claims of the present application and the above-mentioned drawings are intended to cover non-exclusive inclusions. The terms "first", "second", etc. in the specification and claims of the present application or the above-mentioned drawings are used to distinguish different objects, not to describe a specific order.
[0045] Reference to "embodiments" herein means that a particular feature, structure, or characteristic described in conjunction with the embodiments may be included in at least one embodiment of the present application. The appearance of the phrase in various locations in the specification does not necessarily refer to the same embodiment, nor is it an independent or alternative embodiment that is mutually exclusive with other embodiments. It is explicitly and implicitly understood by those skilled in the art that the embodiments described herein may be combined with other embodiments.
[0046] The following examples are provided to facilitate a better understanding of the present invention, but are not intended to limit the present invention. The experimental methods in the following examples are conventional methods unless otherwise specified. The experimental materials used in the following examples are purchased from conventional biochemical reagent stores unless otherwise specified.
[0047] In order to enable those skilled in the art to better understand the solution of the present application, the technical solution in the embodiments of the present application will be clearly and completely described below in conjunction with the accompanying drawings.
[0048] The present application provides a test paper for semi-quantitative detection of leucine aminopeptidase, such as Figure 1 As shown, Figure 1 It is a schematic structural diagram of an embodiment of a test paper for semi-quantitative detection of leucine aminopeptidase according to the present application;
[0049] The test paper comprises a leucine aminopeptidase test paper (101), a blank filter paper (102) and a polyethylene terephthalate substrate; wherein the leucine aminopeptidase test paper and the blank filter paper are arranged in parallel on the polyethylene terephthalate substrate; the leucine aminopeptidase test paper is prepared by soaking the filter paper in a first reaction liquid and a second reaction liquid in sequence, and drying both of the two; the first reaction liquid comprises a surfactant, and the second reaction liquid comprises a chromogenic substrate; the chromogenic substrate comprises L-leucine-4-nitroaniline or 4-nitro-L-phenylalanine methyl ester hydrochloride.
[0050] In this embodiment, the polyethylene terephthalate substrate has a long strip shape, wherein the leucine aminopeptidase test paper (101) and the blank filter paper (102) are sequentially adhered to a surface of the polyethylene terephthalate substrate from left to right along one end of the length direction of the polyethylene terephthalate substrate. The color developing substrate of the second reaction solution is L-leucine-4-nitroaniline or 4-nitro-L-phenylalanine methyl ester hydrochloride, preferably L-leucine-4-nitroaniline. The first reaction solution and the second reaction solution are prepared and used immediately.
[0051] In the present embodiment, the application uses filter paper as a carrier to generate test paper, and the reaction of leucine aminopeptidase can be measured on the test paper to achieve rapid determination. The application provides a test paper for detecting leucine aminopeptidase with excellent stability, and the test paper adopts L-leucyl-β-naphthylamine method. Compared with conventional test kits, the stability and linear range of the test paper are better than conventional detection kits, which is conducive to application. It has simple operation process, short detection time and low detection cost. More importantly, when the application adopts L-leucine-4-nitroaniline as a chromogenic substrate, since L-leucine-4-nitroaniline is fixed on a dry test paper, L-leucine-4-nitroaniline is not present in a liquid reagent, and the spontaneous hydrolysis of L-leucine-4-nitroaniline itself will not be produced, ensuring the accuracy of subsequent determination. Although L-leucine-4-nitroaniline will exist in the second reaction solution for a short time during the preparation process, since the preparation process of the test paper of the present application includes a drying process to evaporate the water, the time that L-leucine-4-nitroaniline exists in the second reaction solution is extremely short, and the spontaneous hydrolysis produced is limited and can be basically ignored, which will not have a substantial impact on the measurement results of the present application, and the sensitivity and accuracy of the measurement can be guaranteed.
[0052] The present application provides urine leucine aminopeptidase test paper that resists bilirubin and vitamin C interference, which is obtained by immersing the test paper in an infusion of N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid buffer, surfactant, preservative, L-leucine-4-nitroaniline, magnesium chloride, potassium ferrocyanide, and fatty alcohol polyoxyethylene ether (Brij-35), which can significantly improve the leucine aminopeptidase test paper with L-leucine-4-nitroaniline as a substrate against bilirubin and vitamin C interference, and enhance the sensitivity and accuracy of the test results. When the bilirubin content in the sample does not exceed 3.5mmol / L and the vitamin C content does not exceed 4.0mmol / L, the leucine aminopeptidase test result is not affected.
[0053] Rationale for this application:
[0054] The reaction principle of urine leucine aminopeptidase determination is as follows: leucine aminopeptidase in urine contacts the test paper, and potassium ferrocyanide in the second reaction solution is used to remove interfering substances such as bilirubin and vitamin C in the sample; after the mixed solution enters the reaction detection tank, L-leucine-4-nitroaniline in the reaction reagent is decomposed under the catalysis of LAP (leucine aminopeptidase) in the test sample, and the absorbance change rate at 405nm is monitored to calculate the concentration of LAP. Leucine aminopeptidase in urine reacts with the chromogenic substrate, and the chromogenic substrate changes from colorless to colored, and the depth of color is positively correlated with the content of leucine aminopeptidase.
[0055]
[0056] As an option in the present application, the second reaction solution also includes chloride, anti-interference substances and lyophilization protectants.
[0057] As an option in the present application, the chloride includes magnesium chloride; the anti-interference substance includes potassium ferrocyanide; and the lyophilization protective agent includes fatty alcohol polyoxyethylene ether (Brij-35).
[0058] In the embodiment, the potassium ferrocyanide is used to avoid the interference of bilirubin in urine. The two substances, anti-interference substances and freeze-drying protective agents, are different from the products on the market. After a large number of experiments, it has been verified that potassium ferrocyanide can inhibit the interference of bilirubin, vitamin C, etc. in urine with leucine aminopeptidase; fatty alcohol polyoxyethylene ether (Brij-35) is a freeze-drying protective agent. After the fixed freeze-drying process of the test paper, the components on the reagent strip will not change, and the test results of urine will not be adversely affected. Among them, the fixed freeze-drying process includes low-temperature drying at -50℃ to 0℃ for 2h to 5h.
[0059] As an option in the present application, the concentration of the chromogenic substrate is 20-200 mol / L; the concentration of the chloride is 30-100 mol / L; the concentration of the anti-interference substance is 10-50 mol / L; and the concentration of the lyophilization protectant is 10-50 mol / L. In this embodiment, optionally, the concentration of the chromogenic substrate includes 20-100mol / L, 100-200mol / L, for example, 20mol / L, 80mol / L, 100mol / L, 150mol / L, 200mol / L; the concentration of the chloride includes 30-50mol / L, 50-100mol / L, for example, 30mol / L, 50mol / L, 70mol / L, 100mol / L; the concentration of the anti-interference substance includes 10-30mol / L, 30-50mol / L, for example, 10mol / L, 20mol / L, 30mol / L, 50mol / L; the concentration of the lyoprotectant includes 10-30mol / L, 30-50mol / L, for example, 10mol / L, 30mol / L, 40mol / L, 50mol / L.
[0060] As an option in the present application, the first reaction solution also includes a buffer and a preservative.
[0061] As an option in the present application, the pH value of the buffer solution of the first reaction solution is 6.50-7.50, and the concentration is 0.01-1.0 mol / L; the concentration of the surfactant is 5-80 g / L; and the concentration of the preservative is 5-300 mol / L.
[0062] In this embodiment, the pH value of the buffer includes 6.50-7.00, 7.00-7.50, for example, 6.50, 7.00, 7.50, and the concentration includes 0.01-0.05 mol / L, 0.05-1.0 mol / L, for example, 0.01 mol / L, 0.05 mol / L, 0.07 mol / L, 1.0 mol / L; the concentration of the surfactant includes 5-40 g / L, 40-80 g / L, for example, 5 g / L, 30 g / L, 60 g / L, 80 g / L; the concentration of the preservative includes 5-200 mol / L, 200-300 mol / L, for example, 5 mol / L, 150 mol / L, 200 mol / L, 300 mol / L.
[0063] As an option in the present application, the buffer of the first reaction solution is selected from at least one of N-tris(hydroxymethyl)methylamino-2-hydroxypropanesulfonic acid buffer and N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid buffer.
[0064] The present application also provides a method for preparing a semi-quantitative test paper for semi-quantitative detection of leucine aminopeptidase, such as Figure 2 As shown, Figure 2 The figure is a flow chart of an embodiment of a method for preparing a semi-quantitative test paper for semi-quantitative detection of leucine aminopeptidase according to the present application; the method comprises the following steps:
[0065] S201: preparing leucine aminopeptidase test paper;
[0066] S202: The leucine aminopeptidase test paper and the pre-prepared blank filter paper are sequentially pasted on one surface of the polyethylene terephthalate (PET) substrate from one end to the other end along the length direction of the PET substrate, and cut into test strips to obtain a semi-quantitative test paper for semi-quantitative detection of urinary leucine aminopeptidase.
[0067] As an option of the present application, the step of preparing the leucine aminopeptidase test paper comprises:
[0068] Prepare the first reaction solution and the second reaction solution;
[0069] Soaking the filter paper in the first reaction solution, fully wetting it and drying it;
[0070] The dried filter paper is immersed in the second reaction solution, fully infiltrated and dried to obtain a leucine aminopeptidase test paper.
[0071] The present application also provides a method for semi-quantitative detection of leucine aminopeptidase for non-diagnostic purposes, such as Figure 3 As shown, Figure 31 is a flow chart of an embodiment of a method for semi-quantitative detection of leucine aminopeptidase according to the present application. The method comprises the following steps:
[0072] S301: Soaking the detection section of the test paper in the urine sample for 1 to 2 seconds;
[0073] S302: Obtain the test result according to the colorimetric card or the test analyzer.
[0074] In this embodiment, the application does not need to collect blood samples for testing and is non-invasive; urine samples are tested using interrupted urine as much as possible to increase the accuracy of the test; a small amount of midstream urine that has been simply processed during the urine sample collection process can be directly taken for testing, which has the advantages of fast, accurate and convenient testing.
[0075] As an option in the present application, the step of obtaining the test result according to the colorimetric card or the detection analyzer includes: reacting for 60 seconds, comparing the reacted test paper with the colorimetric card, and reading the test result.
[0076] As an option of the present application, the step of obtaining the test result according to the colorimetric card or the detection analyzer includes: placing the test paper soaked with the test sample on the urine analyzer, reacting for 60 seconds, and obtaining the test result output by the urine analyzer.
[0077] The specific operation method is as follows:
[0078] 1. Visual judgment: Soak the detection section of the test paper in urine for 1 to 2 seconds. The immersion height should not exceed the urine collection line. Then react for 60 seconds, compare with the colorimetric card, and read the test result.
[0079] 2. Instrument judgment: Soak the detection section of the test paper in urine for 1 to 2 seconds, with the immersion height not exceeding the urine collection line, and place it on a special analyzer (such as a urine analyzer) for 60 seconds. The special analyzer calculates the results through the built-in standard curve and displays them. The results displayed by the special analyzer are the semi-quantitative values of urine leucine aminopeptidase, as shown in Table 1 below, and the semi-quantitative display of the ratio of urine microalbumin to urine creatinine, as shown in Table 2 below.
[0080] Table 1 Results displayed by dedicated analyzer
[0081]
[0082] Table 2 Semi-quantitative results of the ratio of urine microalbumin to urine creatinine
[0083]
[0084] The dedicated urine analyzer is generally controlled by a microcomputer, and uses a spherical integrator to receive dual-wavelength reflected light to measure the color change on the test paper for semi-quantitative determination. The test paper has a reagent pad fixed with a leucine aminopeptidase reagent (i.e., the leucine aminopeptidase test paper of the present application), which reacts independently with the corresponding components in the urine and displays different colors. The depth of the color is proportional to the leucine aminopeptidase in the urine. There is also another "compensation pad" (i.e., the blank filter paper of the present application) in the test paper as the background color of urine to compensate for the errors caused by colored urine and instrument changes.
[0085] Place the test paper adsorbed with urine in the colorimetric chamber of the instrument. The leucine aminopeptidase test paper on which a chemical reaction has occurred is irradiated by the light source, and its reflected light is received by the spherical integrator. The phototube of the spherical integrator is irradiated by the reflected dual-wavelength light (the measurement light passing through the filter and a beam of reference light). The choice of each wavelength is determined by the test item.
[0086] The beneficial effects of the present application are as follows: the present application uses filter paper as a carrier, and the reaction of urinary leucine aminopeptidase can be measured on the test paper. At the same time, leucine aminopeptidase can be quickly semi-quantitatively measured to achieve rapid measurement and non-diagnostic evaluation of liver function in a short time.
[0087] The above scheme is further described below in conjunction with specific implementation examples, but these embodiments are by no means limiting the present application. The preferred embodiments of the present application are described in detail as follows:
[0088] Example 1
[0089] The specific embodiment and preparation of the test paper for semi-quantitative detection of leucine aminopeptidase of the present application are as follows:
[0090] The semi-quantitative test paper for detecting leucine aminopeptidase of the present application comprises: leucine aminopeptidase test paper, blank filter paper and polyethylene terephthalate substrate;
[0091] Wherein, the leucine aminopeptidase test paper and the blank filter paper are arranged side by side on the polyethylene terephthalate substrate;
[0092] The leucine aminopeptidase test paper is prepared by soaking filter paper in a first reaction solution and a second reaction solution in sequence, and drying both of the two solutions.
[0093] Among them, the first reaction liquid component includes a buffer, a surfactant and a preservative, and the second reaction liquid component includes a chromogenic substrate, a chloride, an anti-interference substance and a lyophilization protectant. The pH value of the first buffer is 6.50-7.50, and the concentration is 0.01-1.0 mol / L. The concentration of the surfactant is 5-80 g / L, the concentration of the preservative is 5-300 mol / L, the concentration of the chromogenic substrate is 20-200 mol / L, the concentration of the chloride is 30-100 mol / L, the concentration of the anti-interference substance is 10-50 mol / L, and the concentration of the lyophilization protectant is 10-50 mol / L.
[0094] Examples of the components and concentrations of the first reaction solution and the second reaction solution are shown in the following table:
[0095] Table 3 Composition and concentration of the first reaction solution and the second reaction solution
[0096]
[0097] Preparation of the first reaction solution: weigh corresponding amounts of surfactant and preservative, mix and add appropriate amount of purified water to dissolve; add N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid buffer to dissolve, adjust the pH to 6.20, and finally make up to volume with water.
[0098] Preparation of the second reaction solution: Weigh corresponding amounts of L-leucine-4-nitroaniline, magnesium chloride, potassium ferrocyanide and fatty alcohol polyoxyethylene ether (Brij-35), dissolve them in acetonitrile, stir evenly, and finally make up to volume with acetonitrile.
[0099] Test strip preparation:
[0100] 1) Soak the filter paper in the first reaction solution, and dry it at 37°C for 90 min after it is fully soaked; soak the dried filter paper in the second reaction solution, and dry it at 37°C for 90 min after it is fully soaked; freeze-dry or evaporate at 2-8°C for 24 h to obtain urine leucine aminopeptidase test paper; stick double-sided tape on one side of the leucine aminopeptidase test paper, and cut it into test strips (width: 1 cm, length: 22 cm) for later use.
[0101] 2) The above urine leucine aminopeptidase test paper and blank filter paper are pasted on a polyethylene terephthalate (PET) substrate at a certain interval, and cut into test strips to obtain a semi-quantitative test strip for detecting urine leucine aminopeptidase.
[0102] The present application also uses a dedicated analysis to test the semi-quantitative urine leucine aminotransferase test paper of the present application, and tests the same normal urine sample and abnormal urine sample 10 times each. The test strip is immersed in urine for 1 to 2 seconds, and the immersion height does not exceed the urine collection line. It is placed on a dedicated analyzer and reacts for 60 seconds. The instrument calculates the results through the built-in standard curve. The results displayed for each measurement are shown in the following table:
[0103] Table 4 Precision of repeated determination of samples in Example 1
[0104]
[0105] The above results show that the measurement results of Example 1 are stable and have high precision.
[0106] The test strip prepared in accordance with Example 1 was used to test 50 urine samples on a dedicated analyzer, with the reference test system being ARKRAY's AUTION SCREEN Microalbumin / Creatinine. The coincidence rates of the two were statistically analyzed, and the statistical results are shown in the following table.
[0107] Table 5 Clinical comparison results between Example 1 and ARKRAY
[0108]
[0109]
[0110]
[0111]
[0112] Table 6 Statistical results of clinical consistency between Example 1 and ARKRAY
[0113]
[0114] The above results show that:
[0115] The consistency between the results of Example 1 and ARKRAY's AUTION SCREEN Microalbumin / Creatinine assay was greater than 0.8, and the clinically relevant compliance rate was high.
[0116] It should be understood that, although the steps in the flowchart of the accompanying drawings are displayed in sequence as indicated by the arrows, these steps are not necessarily executed in sequence in the order indicated by the arrows. Unless otherwise specified herein, there is no strict order restriction on the execution of these steps, and they can be executed in other orders. Moreover, at least a part of the steps in the flowchart of the accompanying drawings may include multiple sub-steps or multiple stages, and these sub-steps or stages are not necessarily executed at the same time, but can be executed at different times, and their execution order is not necessarily sequential, but can be executed in turn or alternately with other steps or at least a part of the sub-steps or stages of other steps.
[0117] Obviously, the embodiments described above are only some embodiments of the present application, rather than all embodiments. The preferred embodiments of the present application are given in the accompanying drawings, but they do not limit the patent scope of the present application. The present application can be implemented in many different forms. On the contrary, the purpose of providing these embodiments is to make the understanding of the disclosure of the present application more thorough and comprehensive. Although the present application is described in detail with reference to the aforementioned embodiments, for those skilled in the art, it is still possible to modify the technical solutions recorded in the aforementioned specific implementation methods, or to perform equivalent replacement of some of the technical features therein. Any equivalent structure made using the contents of the specification and drawings of this application, directly or indirectly used in other related technical fields, is similarly within the scope of patent protection of this application.
Claims
1. A test paper for semi-quantitative detection of leucine aminopeptidase, characterized in that: include: Leucine aminopeptidase test paper, blank filter paper, and polyethylene terephthalate substrate; Wherein, the leucine aminopeptidase test paper and the blank filter paper are arranged side by side on the polyethylene terephthalate substrate; The leucine aminopeptidase test paper is prepared by soaking filter paper in the first reaction solution and the second reaction solution in sequence, and drying both of them; The first reaction solution includes a surfactant, and the second reaction solution includes a color developing substrate; The chromogenic substrate includes L-leucine-4-nitroaniline or 4-nitro-L-phenylalanine methyl ester hydrochloride.
2. The test paper for semi-quantitative detection of leucine aminopeptidase according to claim 1, characterized in that: The second reaction solution also includes chloride, anti-interference substance and freeze-drying protective agent.
3. The test paper for semi-quantitative detection of leucine aminopeptidase according to claim 2, characterized in that: The chloride comprises magnesium chloride; and / or The anti-interference substance includes potassium ferrocyanide; and / or The lyophilization protective agent includes fatty alcohol polyoxyethylene ether.
4. The test paper for semi-quantitative detection of leucine aminopeptidase according to claim 2, characterized in that: The concentration of the chromogenic substrate is 20 to 200 mol / L; and / or The concentration of the chloride is 30 to 100 mol / L; and / or The concentration of the anti-interference substance is 10 to 50 mol / L; and / or The concentration of the lyophilization protective agent is 10-50 mol / L.
5. The test paper for semi-quantitative detection of leucine aminopeptidase according to claim 1, characterized in that: The first reaction solution also includes a buffer and a preservative.
6. The test paper for semi-quantitative detection of leucine aminopeptidase according to claim 5, characterized in that: The pH value of the buffer solution is 6.50-7.50, and the concentration is 0.01-1.0 mol / L; and / or The concentration of the surfactant is 5 to 80 g / L; and / or The concentration of the preservative is 5 to 300 mol / L.
7. The test paper for semi-quantitative detection of leucine aminopeptidase according to claim 5, characterized in that: The buffer of the first reaction solution is selected from at least one of N-tris(hydroxymethyl)methylamino-2-hydroxypropanesulfonic acid buffer and N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid buffer.
8. A method for semi-quantitative detection of leucine aminopeptidase for non-diagnostic purposes, using the test paper for semi-quantitative detection of leucine aminopeptidase according to any one of claims 1 to 7, characterized in that: The steps include: Soak the detection section of the test paper in the urine sample for 1 to 2 seconds; The test results are obtained according to the colorimetric card or the detection analyzer.
9. The method for semi-quantitative detection of leucine aminopeptidase according to claim 8, characterized in that: The step of obtaining the test result according to the colorimetric card or the detection analyzer comprises: Allow to react for 60 seconds, compare the reacted test paper with the colorimetric card, and read the test result.
10. The method for semi-quantitative detection of leucine aminopeptidase according to claim 8, characterized in that: The step of obtaining the test result according to the colorimetric card or the detection analyzer comprises: The test paper soaked with the test sample is placed on the urine analyzer and reacted for 60 seconds to obtain the test result output by the urine analyzer.
